Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer

Technology appraisal guidance
Reference number: TA192
Published: 28 July 2010

Lung cancer (non-small-cell, first line) - gefitinib: appendix a - provisional matrix of stakeholders

Lung cancer (non-small-cell, first line) - gefitinib: appendix a - provisional matrix of stakeholders

Lung cancer (non-small-cell, first line) - gefitinib: appendix a - provisional matrix of stakeholders
10 October 2014
(100.37 Kb 29 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 10 October 2014